1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Affective Psychosis, Bipolar in 1 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napolitano, F | 1 |
| Booth Warren, E | 1 |
| Migliarini, S | 1 |
| Punzo, D | 1 |
| Errico, F | 1 |
| Li, Q | 1 |
| Thiolat, ML | 1 |
| Vescovi, AL | 1 |
| Calabresi, P | 1 |
| Bezard, E | 1 |
| Morelli, M | 1 |
| Konradi, C | 1 |
| Pasqualetti, M | 1 |
| Usiello, A | 1 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Animals; Bipolar Disorder; Br | 2017 |